Al Marjan Island to feature Marriott International's second hospitality offering on its shores: W Al Marjan Island
Marjan, the master developer of freehold properties in Ras Al Khaimah, today announced the launch of a W Hotel on Al Marjan Island on the back of a collaboration between Marriott International, Inc., and Dalands Holding.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230831309529/en/
Al Marjan Island to feature Marriott International's second hospitality offering on its shores: W Al Marjan Island (Photo: AETOSWire)
Slated for a grand opening early 2027, W Al Marjan Island is poised to achieve a dual distinction, not only as Marriott International’s second hospitality venture on the island, but also as W Hotel’s first property in Ras Al Khaimah, bringing the brand’s bold design, outstanding service and always-on programming to the northern emirate.
Destined to be located on Marjan’s flagship archipelago island, set against the picturesque backdrop of the Arabian Peninsula, and enclosed by the Yanas and Jais Mountains, the hotel will further elevate the appeal of this thriving leisure destination to globetrotters.
Featuring an inventory of 300 hotel rooms and suites with sweeping sea views, this magnificent property is anticipated to include signature spaces such as the Living Room, WET deck, W Lounge, AWAY Spa, and FIT fitness centre along with three restaurants and retail spaces.
Abdulla Al Abdouli, Chief Executive Officer, Marjan, said: “As Ras Al Khaimah rightfully solidifies its position on the global tourism landscape, we take pride in our significant contribution to enhancing its credibility and attractiveness among international investors. This commitment has led to a myriad of prestigious projects, as exemplified by the launch of W Al Marjan Island.”
"We are excited to work with Dalands Holding to bring W's invigorating energy and dynamic design to Al Marjan Island,” said Saahil Lalit, Vice President – Development, Middle East, Marriott International. “Ras Al Khaimah continues to be a sought-after leisure destination attracting global travellers to its idyllic beaches and attractions.”
Saurabh Gupta, CEO, Dalands Holding, said: "We believe this one-of-a-kind development will be immensely popular for its iconic design, luxurious accommodation and trendy culinary options. Like the other luxury hotels in our portfolio, we are developing W Al Marjan Island around the perceived needs of our future guests by curating exceptional offerings and unforgettable experiences.”
Endowed with white sandy beaches stretching over 7.8 km and a 23 km waterfront, an array of activities, and water sports, Al Marjan Island is reimagining luxurious waterfront living in Ras Al Khaimah.
*Source: AETOSWire
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230831309529/en/
Contact information
Nivine William
nivine.william@bcw-global.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Takeda Provides Update on EXKIVITY® (mobocertinib)2.10.2023 23:30:00 EEST | Press release
Takeda (TSE:4502/NYSE:TAK) today announced that, following discussions with the U.S. Food and Drug Administration (FDA), it will be working with the FDA towards a voluntary withdrawal of EXKIVITY ® (mobocertinib) in the U.S. for adult patients with epidermal growth factor receptor (EGFR) Exon20 insertion mutation-positive (insertion+) locally advanced or metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on or after platinum-based chemotherapy. Takeda intends to similarly initiate voluntary withdrawal globally where EXKIVITY is approved and is working with regulators in other countries where it is currently available on next steps. This decision was based on the outcome of the Phase 3 EXCLAIM-2 confirmatory trial, which did not meet its primary endpoint and thus did not fulfill the confirmatory data requirements of the Accelerated Approval granted by the U.S. FDA nor the conditional marketing approvals granted in other countries. The EXCLAIM-2 trial was a Phase
Galderma announces progress with RelabotulinumtoxinA regulatory submissions2.10.2023 23:27:00 EEST | Press release
Galderma, the emerging pure-play dermatology category leader, announced today updates related to the regulatory progress of its pending Biologics License Application (“BLA”) for RelabotulinumtoxinA (QM-1114) to the U.S. Food and Drug Administration (“FDA”). The FDA has issued a Complete Response Letter (“CRL”) to Galderma related to its BLA for RelabotulinumtoxinA for the treatment of moderate-to-severe glabellar lines (frown lines) associated with corrugator and/or procerus muscle activity in adult patients as well as moderate-to-severe lateral canthal lines (crow’s feet) associated with orbicularis oculi muscle activity in adult patients. The CRL points out certain deficiencies isolated to items related to Chemistry, Manufacturing, and Controls (“CMC”) processes. All other aspects of the BLA, including safety and efficacy related parts, did not solicit deficiencies to be addressed. Galderma has already identified changes to the manufacturing process to address feedback. It will also
Visa Launches $100 million Generative AI Ventures Initiative2.10.2023 23:05:00 EEST | Press release
Visa (NYSE: V), a global leader in payments, today announced a new $100 million generative AI ventures initiative to invest in the next generation of companies focused on developing generative AI technologies and applications that will impact the future of commerce and payments. As a pioneer of AI use in payments since 1993, Visa considers this initiative an extension of Visa’s leadership in using AI to drive innovation in payments, create value for partners and clients, and enable and empower global commerce. Generative AI is an emerging subset of AI that is built on Large Language Models (LLMs) to develop artificial general intelligence capable of generating text, images or other content from large sets of existing data when given prompts. “While much of generative AI so far has been focused on tasks and content creation, this technology will soon not only reshape how we live and work, but it will also meaningfully change commerce in ways we need to understand,” said Jack Forestell,
MSCI Completes Acquisition of Burgiss2.10.2023 23:05:00 EEST | Press release
MSCI Inc. (NYSE: MSCI), a leading provider of mission-critical decision support tools and services for the global investment community, today announced that it has completed its acquisition of The Burgiss Group, LLC (“Burgiss”), a market-leading provider of data, analytics, and technology solutions for investors in private assets. The acquisition was originally announced on August 14, 2023. Henry Fernandez, Chairman and Chief Executive Officer, MSCI, said: “We are thrilled to complete this acquisition. By making Burgiss part of our integrated franchise, MSCI will dramatically expand and strengthen our solutions across client segments. In the process, we will help promote greater transparency for investors in private assets." About MSCI Inc. MSCI is a leading provider of critical decision support tools and services for the global investment community. With over 50 years of expertise in research, data, and technology, we power better investment decisions by enabling clients to understand
Carbios Unveils Major Innovation in Polyester Recycling With New Textile Preparation Line, in the Presence of Roland Lescure, French Minister of Industry2.10.2023 19:00:00 EEST | Press release
Regulatory News: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231002227008/en/ Roland Lescure, French Minister of Industry (left) accompanied by Emmanuel Ladent, CEO Carbios (far right) and representatives of Carbios partner brands (On, Salomon and Puma), inaugurates the textile preparation line for biorecycling. (Photo: Carbios) Carbios, (Euronext Growth Paris: ALCRB), a pioneer in the development and industrialization of biological technologies to reinvent the life cycle of plastic and textiles, today inaugurated its textile preparation line at its demonstration plant in Clermont-Ferrand, in the presence of Mr. Lescure, French Minister for Industry. To streamline the textile preparation phase, which is currently carried out by hand or on several lines, Carbios has developed a fully integrated and automated line that transforms textile waste from used garments or cutting scraps into raw material suitable for depolymerizat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom